• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus activity in the world (WHO, March 15 2013): Some oseltamivir-resistant H1N1pdm09 viruses detected

Giuseppe

Emeritus
[Source: World Health Organization, full page: (LINK). Edited.]

Influenza virus activity in the world

15 March 2013


Source: Laboratory confirmed data from the Global Influenza Surveillance and Response System (GISRS).



Based on FluNet reporting (as of 12 March 2013, 10:45 UTC), during weeks 8 to 9 (17 February 2013 to 2 March 2013), National Influenza Centres (NICs) and other national influenza laboratories from 101 countries, areas or territories reported data.

The WHO GISRS laboratories tested more than 79 430 specimens. 20 386 were positive for influenza viruses, of which 12 859 (63.1%) were typed as influenza A and 7 527 (36.9%) as influenza B.

Of the sub-typed influenza A viruses, 5 355 (62.1%) were influenza A(H1N1)pdm09 and 3 264 (37.9%) were influenza A(H3N2).

Of the characterized B viruses, 432 (89.8%) belonged to the B-Yamagata lineage and 49 (10.2%) to the B-Victoria lineage.



Summary

During weeks 8 and 9, influenza activity declined in the northern hemisphere and remained low in the southern hemisphere. Influenza A(H1N1)pdm09 viruses remained the predominant virus circulating globally, followed by A(H3N2) and influenza B viruses.

In the European region, influenza activity continued to decline.

While influenza A(H1N1)pdm09 and B viruses co-circulated in many parts of Europe, A(H1N1)pdm09 viruses were predominant in eastern and south western Europe.

Five A(H1N1)pdm09 viruses with reduced susceptibility to oseltamivir were detected in the Netherlands, Switzerland and United Kingdom.

Of the five, three cases reported history of oseltamivir treatment.

One influenza B virus with reduced susceptibility to oseltamivir was detected from a case in the United Kingdom with no exposure to antiviral treatment.

In North America, influenza activity decreased in general with B viruses becoming predominant.

In Asia, in southern China influenza activity associated with A(H1N1)pdm09 viruses continued to increase, while it decreased in the northern parts.

A(H3N2) activity was reported from a number of other countries in the region at varying levels.

Sporadic detections of influenza viruses continued to be reported from the African region. Influenza B was the predominant virus detected, followed by A(H1N1)pdm09 and A(H3N2) viruses.

Influenza activity remained low in Central and South America with A(H3N2) and influenza B viruses detected at low levels.


(?)


-
-------
 
Back
Top Bottom